https://ipharmag.com/article/what-is-a-jak-inhibitor-explained-uses-side-effects iPharmag en 2026-10-01T12:41:35+00:00 What Is a JAK Inhibitor? How They Work, What They Treat, and the Risks to Know https://ipharmag.com/article/sanofi-regeneron-8b-long-acting-dupixent-successors iPharmag en 2026-10-01T12:41:35+00:00 Sanofi and Regeneron Strike an $8 Billion Deal to Build Dupixent’s Successors https://ipharmag.com/article/fda-approves-camzyos-adolescents-obstructive-hcm iPharmag en 2026-10-01T12:41:35+00:00 FDA Expands Camzyos to Teenagers With Obstructive Hypertrophic Cardiomyopathy